Investors hoping for a revival at the struggling biotech might want to temper their expectations. Few drug developers successfully bring a product to market. Fewer still earn multiple regulatory approvals. Bluebird Bio (BLUE) – Get Read more…
Americans are saving less money than ever as inflation and higher interest rates have impacted their budgets. The American consumer is accumulating less money each month and tapping into their savings to pay for basic Read more…
Young electric vehicle maker is trying to allay fears over its ability to mass-produce. It’s a big relief. Rivian (RIVN) – Get Rivian Automotive Inc. Report, the young manufacturer of electric vehicles, finally has good Read more…
Amazon will hold its second Prime sale of the year later this month. Here’s how the charts are shaping up now. Amazon (AMZN) – Get Amazon.com Inc. Report has been a really interesting stock so far Read more…
Prime Medicine, a third-generation Crispr company, may test the choppy waters of the stock market with an IPO. In the current environment, companies may do better staying private than going public. But Prime Medicine may Read more…
Welcome to Technical Tuesday, a weekly report where we highlight some of the most interesting markets that will hopefully appease technical analysts and traders alike. In this week’s edition, we are getting technical on the Read more…
San Francisco Fed President Mary Daly said Fed needs to raise interest further and hold restrictive policies in place until it’s “truly done” on bring back inflation to 2% target. “Those interest rate increases slow Read more…
The Swiss bank is due to unveil its turnaround plan on Oct. 27, a deadline employees say is too far off given the circumstances. For Credit Suisse (CS) – Get Credit Suisse Group American Depositary Read more…
The latest US employment report will rock financial markets at 12:30 GMT Friday. With the Fed actively trying to weaken the labor market, the stakes are very high. However, it seems like Powell won’t get Read more…
The Reserve Bank of Australia raised its rate by 25 points to 2.6%, against an expected increase to 2.85%. Previously, the rate had been hiked by 50 points four times since June. The same decision Read more…